iCoat Medical is a clinical stage, immunotherapy company focusing on reducing and preventing ischemia reperfusion injuries by developing novel pharmaceutical products.
The company is one of the world’s leading R&D-centered organizations within innate immunology and is systematically expanding its pipeline using its proprietary coating-technology platform. iCoat Medical’s lead candidate TUM012 is developed to improve the outcome of organ transplantations.
iCoat Medical’s unique ex-vivo coating of the grafts has the ambition of being an integral part in the transplant procedures of tomorrow. iCoat Medical has operations in Uppsala, Lund and Malmö, and is headquartered in Stockholm.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Malmskillnadsgatan 32, Stockholm,11151,sweden
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.icoatmedical.com/
- Keywords
- IT Consulting.
- HQ
- Stockholm
Icoat Medical Ab Questions
Icoat Medical Ab's website is https://www.icoatmedical.com/
Icoat Medical Ab's LinkedIn profile is https://se.linkedin.com/company/icoat-medical
Icoat Medical Ab has
6 employees.
View email and phone details for 6
employees at Icoat Medical Ab.
Icoat Medical Ab's industry is
Pharmaceutical Manufacturing
Icoat Medical Ab's top competitors are
B2b Leads Expert,
Sustainable Advantage Ab,
Lea Cares,
Prosmedic,
Ctc Clinical Trial Consultants Ab,
Northx Biologics,
The Swedish Association Of The Pharmaceutical Industry, Lif,
Sprint Bioscience,
Truly Labs,
Bioced.
Icoat Medical Ab's categories are Pharmaceutical Manufacturing
Icoat Medical Ab's founding year is 2018
